What are Money-Magnet Moderna’s future plans? French Founding CEO explains here

Before the end of the mRNA conference in Berlin, I had to interview Stephane Bancel, the French founding CEO of Moderna…one of the biggest deals in Biotech today.

moderna_logoModerna is the mRNA therapies companies from Cambridge/Boston (US), most famous for having raised over 900 million dollars in VC money. I met Stephane one and a half years ago during our Labiotech Tour Boston, and this interview was a great opportunity to catch-up and ask how things have been moving forward since…

Moderna is the leader in mRNA Therapeutics, with pipelines which spanning fields to include rare disease, Oncology, ‘BioDefense’, chronic and infectious disease. Their impressive network of partners and research institutions (including Institut Pasteur) has granted them a strong foothold in the industry, which earlier this year raked in the highest VC investment rounds into a single Biotech ever.


Personal comment: It was also a great reminder of all my Boston memories and why it’s so much of a great city for Biotech.

Anyway – here is the interview:

Let's Continue The Conversation

Feel free to send us comments about this article to comments@labiotech.eu and/or comment on that article on social media.

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and its' freely accessible content.